PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

A fairly extensive equine study that was published in the...

  1. 1,316 Posts.
    lightbulb Created with Sketch. 263
    A fairly extensive equine study that was published in the Journal of Arthritis concluded with the following...

    Conclusions: NaPPS resulted in signifcant improvement in clinical signs and articular cartilage healing, and no adverse effects were detected confrming that NaPPS has disease-modifying properties.

    The full study, along with medical imaging, can be found online. I will copy and paste the link in another post. Well worth a read.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
23.5¢ 24.0¢ 22.5¢ $186.1K 801.8K

Buyers (Bids)

No. Vol. Price($)
4 33599 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 65498 1
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.